BETHLEHEM, Pa., Sept. 21, 2021 /PRNewswire/ — B. Braun Medical Inc. (B. Braun), a leader in infusion therapy and pain management, announced today the launch of its new CARESAFETM IV Administration ...
A patient with a low potassium level was due to receive three sequential, hour-long infusions of highly concentrated potassium chloride 20 mEq in minibags. A primary IV of 0.9% sodium chloride was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback